Expert Speakers

Discover what hot new speakers and returning KOLs will be presenting at the 4th Longevity Therapeutics Summit in San Francisco this June.

Anastasiya Giarletta

Principal

R42 Group

Andrei Gudkov

Chief Scientific Officer

Genome Protection, Inc

Anurag Singh

Chief Medical Officer

Amazentis

Benedetta Robilant

Chief Scientific Officer

Dorian Therapeutics

Benjamin Yaden

Senior Director, Advisor

Eli Lilly

Birgit Schilling

Associate Professor Proteomics and Aging

Buck Institute for Research on Aging

David Furman

Associate Professor Proteomics and Aging

Buck Artificial Intelligence Platform

Doug Ethell

Chief Executive Officer

Leucadia Therapeutics

Eric Verdin

Chief Executive Officer & President

The Buck Institute for Research on Aging

Erik Stoops

Head of Development

ADx NeuroSciences

Erin Kimbrel

VP, Research

Astellas Institute for Regenerative Medicine

Joe Sarret

CEO

CohBar

John Cooke

Chief Technology Officer

Houston Methodist Academic Institute

Karl Pfleger

Founder

AgingBiotech.info

Kate Batz

Director

Deep Knowledge Investors

Keshav K Singh, PhD

Joy and Bill Harbert Endowed Chair and Professor

Heersink School of Medicine, University of Alabama at Birmingham

Louis Hawthorne

Chief Executive Officer

NaNotics

Marco Quarta

Co-Founder & Chief Executive Officer

Rubedo Life Sciences

Mark Allen

Co-Founder & Chief Executive Officer

Elevian

Matt Kaeberlein

Professor

University of Washington

Michael Fossel

President

Telocyte

Michelle Keller

Senior Manager of Scientific BD

Deep Longevity Limited

Misha Shchepinov

Chief Scientific Officer

Retrotope

Nir Barzilai

Director

The Institute for Aging Research at the Albert Einstein College of Medicine

Guna Rajagopal

Scientific Vice President & Fellow, Computational Sciences

Janssen

Pinchas Cohen

Dean. Co-founder

Leonard Davis School of Gerontology. CohBar

Robin Mansukhani

Chief Executive Officer

Deciduous Therapeutics

Stanislas Veillet

Chief Executive Officer

Biophytis

Viktoria Kheifets

Senior Vice President

Alkahest

William Greene

Chief Executive Officer

Fountain Therapeutics